Table 3.

The ongoing phase 3 clinical trials evaluating an adjuvant therapy for hepatocellular carcinoma.

Trial	Arms	Clinicaltrials.gov identifier	Sponsor
CheckMate 9DX	nivolumab vs. placebo	NCT03383458	BMS
KEYNOTE-937	pembrolizumab vs. placebo	NCT03867084	MSD
EMERALD-2	durvalumab + bevacizumab vs. durvalumab + placebo vs. placebo	NCT03847428	AstraZeneca
JUPITER 04	toripalimab (JS001) vs. placebo	NCT03859128	Junshi
IMbrave050	atezolizumab + bevacizumab vs. no therapy	NCT04102098	Roche